Teens Age 12-17 with Asthma

Trial Objective

The purpose of this study is to determine if an investigational medication, Fevipiprant, improves breathing in teens with uncontrolled asthma.

Teen Asthma Investigational Medication

Study details:

  • 9 visits to National Jewish Health over a 5 month period
  • Investigational medicine is taken in addition to standard-of-care therapy and is in the form of a pill
  • Medical evaluations (including breathing tests and physical examinations) at no cose
  • Asthma education
  • Financial compensation for time and travel for qualified participants

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, call 303.398.1470 or complete the form below.

Who Can Participate

Teens age 12-17 with a diagnosis of asthma for at least six months who are being treated with daily asthma medications may be eligible to participate.


Estimated Time Commitment

About 9 visits over approximately 19 weeks

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

Novartis Pharmaceuticals Corporation

Age

12-17


Gender

Any Gender

Principal Investigators


Request More Information

*
*
*
*